Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Pediatr Gastroenterol Nutr ; 59(3): 334-9, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24854897

ABSTRACT

OBJECTIVES: The aim of the present study was to assess the prevalence and patterns of complementary and alternative medicine (CAM) use among pediatric patients with gastrointestinal (GI) disorders at academic clinics in Canada. METHODS: The survey was carried out at 2 hospital-based gastroenterology clinics: the Stollery Children's Hospital in Edmonton and the Children's Hospital of Eastern Ontario (CHEO) in Ottawa. RESULTS: CAM use at the Stollery was 83% compared with 36% at CHEO (P < 0.001). The most common reason for not using CAM was lack of knowledge about it. Most respondents felt comfortable discussing CAM in their clinic and wanted more information on CAM. The most common CAM products being taken were multivitamins (91%), calcium (35%), vitamin C (32%), probiotics (14%), and fish oil/omega-3 fatty acids (13%). The most common CAM practices being used were massage (43%), chiropractic (27%), faith healing (25%), and relaxation (18%). Most respondents believed that CAM was helpful, and most of the 23 reported adverse effects were minor. Seven were reported as moderate, and 3 were reported as severe. Many (42%) patients used CAM at the same time as prescription medicines, and of these patients, concurrent use was discussed with their physician (76%) or pharmacist (52%). CONCLUSIONS: CAM use is high among pediatric patients with GI disorders and is much greater among those in Edmonton than in Ottawa. Most respondents reported their CAM use as helpful, with little or no associated harm. Many patients fail to disclose their concurrent use of CAM and conventional medicines to their doctors, increasing the likelihood of interactions.


Subject(s)
Complementary Therapies/statistics & numerical data , Digestive System Diseases/therapy , Health Knowledge, Attitudes, Practice , Academic Medical Centers , Adolescent , Adult , Alberta , Caregivers/statistics & numerical data , Child , Child, Preschool , Complementary Therapies/adverse effects , Dietary Supplements/statistics & numerical data , Faith Healing/statistics & numerical data , Female , Humans , Male , Manipulation, Chiropractic/statistics & numerical data , Massage/statistics & numerical data , Middle Aged , Ontario , Outpatient Clinics, Hospital , Physician-Patient Relations , Probiotics/therapeutic use , Relaxation Therapy/statistics & numerical data
2.
Biochem Biophys Res Commun ; 436(1): 79-84, 2013 Jun 21.
Article in English | MEDLINE | ID: mdl-23707942

ABSTRACT

The underlying mechanisms of microRNA deregulation in cancer cells include epigenetic modifications, which play a crucial role in carcinogenesis. We demonstrate that numerous microRNAs are induced in renal cell carcinoma cell lines after treatment with inhibitors of the DNA-methyltransferase (5-aza-2'-deoxycytidine) and the histone-deacetylase (suberoylanilide hydroxamic acid). We provide evidence that enrichment of H3 and H3K18 acetylation at the miR-9 promoter is causative for re-expression, while DNA hypermethylation remains unchanged. Our experiments show that the treatment with the epigenetic drugs causes re-expression of silenced microRNAs with putative tumor suppressive function in ccRCC cell lines.


Subject(s)
Carcinoma, Renal Cell/metabolism , Epigenesis, Genetic , Kidney Neoplasms/metabolism , MicroRNAs/metabolism , Azacitidine/analogs & derivatives , Azacitidine/pharmacology , Carcinoma, Renal Cell/genetics , Cell Line, Tumor , Cell Proliferation , Cell Survival , DNA Methylation , DNA Modification Methylases/metabolism , Decitabine , Gene Expression Regulation, Neoplastic , Gene Silencing , Histone Deacetylases/metabolism , Histones/metabolism , Humans , Hydroxamic Acids/pharmacology , Kidney Neoplasms/genetics , Promoter Regions, Genetic , RNA/metabolism , Vorinostat
SELECTION OF CITATIONS
SEARCH DETAIL
...